Induction Period Characterisation

Induction period characterisation identifies time delay before pharmaceutical therapeutic effects manifest. Delayed onset reflects time required for drug accumulation at target. Steady-state achievement involves multiple half-lives. Chronic disease treatments frequently require prolonged induction. Patient counselling addresses expectations during induction.

Stability of response after induction indicates sustained efficacy. Inadequate response during induction prompts regimen reconsideration. Regulatory submissions highlight induction period clinical implications. Post-approval monitoring confirms induction timelines. Biomarker assessment detects early response indicators.